YOLFTbeta
00

Zhuhai Rundu Pharmaceutical Co Ltd Class A

002923 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

8.99CNY-0.17 (-1.86%)

Price History

Full chart

Market Stats

Previous Close9.16
Open9.15
Day Range8.95 – 9.19
52-Week Range9.02 – 18.96
Volume4.58M
Market Cap3.69B
P/E (TTM)275.25
Forward P/E0.00
EPS0.04
Dividend Yield0.00%
Beta0.01
50-Day Avg10.99
200-Day Avg12.55

About

Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceutical intermediates in China and internationally. It offers FDF for cardiovascular, gastrointestinal, antibiotics, analgetic and antipyretics, anti-virus, endocrinology, and respiratory; and pellets for excipient, antiulcerative, diabetes drug, anti-inflammatory, and anti-anginals. The company is also involved in the process development, quality research, and registration of chemical drugs. In addition, it provides branding services of drug products, as well as academic services. The company was founded in 1999 and is headquartered in Zhuhai, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jie Liu
  • Employees1.66K
  • HeadquartersNo. 6, North Airport Road, Zhuhai, China, 519041, China
  • Websitehttps://www.rdpharma.cn

Leadership

  • Mr. Jie LiuGM & Director · b. 1976
  • Mr. Shenhua ShiDeputy GM, CFO & Accounting Supervisor · b. 1963
  • Mr. Jun SuDeputy GM & Board Secretary · b. 1981
  • Mr. Qiang CaiDeputy General Manager · b. 1978
  • Mr. Wei ChenDeputy General Manager · b. 1981
  • Mr. Jun LiuDeputy General Manager · b. 1968

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue311.18M361.93M434.13M523.60M577.94M651.86M779.42M1.04B1.36B1.25B1.19B1.37B1.29B1.18B1.18B
Growth (%)-+16.31%+19.95%+20.61%+10.38%+12.79%+19.57%+33.93%+30.28%-7.89%-5.01%+15.32%-5.86%-8.48%-0.51%
Cost of Revenue102.31M131.00M145.71M174.07M194.67M235.17M275.72M261.54M389.54M491.79M478.84M636.32M685.03M691.90M722.18M
Gross Profit208.87M230.94M288.42M349.53M383.27M416.69M503.70M782.32M970.37M760.84M711.09M735.92M606.86M490.47M454.19M
Gross Margin67.12%63.81%66.44%66.75%66.32%63.92%64.62%74.94%71.36%60.74%59.76%53.63%46.97%41.48%38.61%
Operating Expense169.28M169.02M222.61M285.36M304.90M330.98M399.74M662.48M836.82M607.26M557.31M554.56M520.59M446.38M432.19M
Operating Income39.59M61.92M65.81M64.17M78.37M85.71M103.96M119.84M133.55M153.58M153.78M181.35M86.27M44.09M21.99M
Operating Margin12.72%17.11%15.16%12.26%13.56%13.15%13.34%11.48%9.82%12.26%12.92%13.22%6.68%3.73%1.87%
EBITDA41.23M67.92M71.06M73.13M86.57M125.55M138.30M154.22M173.94M201.89M214.27M257.79M214.14M193.85M96.67M
EBITDA Margin13.25%18.77%16.37%13.97%14.98%19.26%17.74%14.77%12.79%16.12%18.01%18.79%16.58%16.40%8.22%
Net Income32.21M56.60M59.36M59.52M71.17M87.47M90.65M106.84M118.90M135.86M139.77M155.48M66.90M39.88M-63.47M
Net Income Margin10.35%15.64%13.67%11.37%12.31%13.42%11.63%10.24%8.74%10.85%11.75%11.33%5.18%3.37%-5.40%
R&D-11.52M12.94M16.12M18.63M30.05M44.69M66.02M114.54M102.47M92.14M95.59M129.44M131.27M94.12M
R&D as % of Total Revenue-3.18%2.98%3.08%3.22%4.61%5.73%6.32%8.42%8.18%7.74%6.97%10.02%11.10%8.00%
Interest Expense885.62K--2.52M2.60M4.64M5.91M3.10M3.89M3.08M2.63M7.42M17.24M17.44M13.11M
Interest Expense % of Total Revenue0.28%--0.48%0.45%0.71%0.76%0.30%0.29%0.25%0.22%0.54%1.33%1.47%1.11%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets238.62M294.06M344.54M375.41M499.72M616.60M706.00M1.14B1.33B1.51B1.91B2.29B2.23B2.19B2.03B
Total Liabilities73.29M94.63M108.25M102.10M189.00M218.42M217.16M267.13M386.39M475.54M797.28M1.09B1.05B1.04B990.19M
Total Equity165.33M199.43M236.29M273.31M310.72M398.19M488.84M871.29M940.29M1.04B1.11B1.20B1.18B1.15B1.04B
Cash61.10M86.08M82.56M92.49M104.58M149.53M168.10M182.50M197.82M251.68M250.30M221.03M213.86M206.51M256.17M
Total Debt20.00M20.00M29.60M29.60M93.40M113.00M85.23M47.27M29.53M69.38M286.61M468.43M501.89M392.28M-
Net Debt-41.10M-66.08M-52.96M-62.89M-11.18M-36.53M-82.87M-135.24M-168.29M-182.31M36.30M247.40M288.03M185.76M186.59M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow33.71M70.01M31.67M58.01M50.14M94.07M57.95M159.04M151.30M250.35M205.91M135.01M172.68M211.19M104.41M
Investing Cash Flow-60.86M-21.23M-24.51M-19.16M-66.03M-63.87M-4.72M-381.00M-89.68M-163.11M-332.06M-251.56M-174.53M-81.17M-
Financing Cash Flow-970.07K-23.81M-10.49M-30.93M30.02M13.65M-32.53M236.52M-51.27M-58.48M155.01M73.20M-4.48M-157.75M-
Capital Expenditure60.89M20.75M24.51M19.17M66.05M63.87M36.40M115.31M240.01M256.74M376.48M251.75M174.53M81.25M17.96M
Free Cash Flow-27.18M49.26M7.16M38.84M-15.91M30.20M21.56M43.74M-88.71M-6.40M-170.58M-116.75M-1.85M129.94M86.44M
Dividends Paid970.07K23.76M20.12M28.77M35.95M5.60M5.11M70.00M74.17M74.38M74.35M74.27M102.38M84.70M64.09M
FCF to OCF-80.63%70.36%22.61%66.96%-31.73%32.10%37.20%27.50%-58.63%-2.55%-82.84%-86.47%-1.07%61.53%82.79%
Dividend Paid to FCF-3.57%48.23%281.00%74.06%-225.95%18.53%23.73%160.05%-83.60%-1162.84%-43.59%-63.62%-5520.44%65.18%74.14%

Earnings

Report DateMar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 17, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate---------------------------------
EPS Actual0.070.100.090.080.090.110.100.060.100.130.100.070.100.090.070.150.110.110.080.160.120.09-0.010.000.090.03-0.000.010.01-0.11-0.06-0.030.05
Surprise---------------------------------
Timing------------------------After-hours---After-hours----

Key Statistics & Ratios

Market Cap3.69B
Enterprise Value3.85B
Trailing P/E275.25
Forward P/E0.00
Price / Sales2.76
Price / Book3.43
EPS0.04
Book Value3.22
Revenue (TTM)1.34B
Gross Profit (TTM)528.83M
EBITDA192.74M
Profit Margin1.01%
Operating Margin4.23%
Return on Equity1.26%
Return on Assets1.54%
Shares Outstanding334.89M
Shares Float128.11M
Beta0.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
0.15May 30, 2025
20241×
0.20May 31, 2024
20231×
0.35May 31, 2023
20221×
0.29May 27, 2022
20211×
0.22May 28, 2021
20201×
0.22Jun 9, 2020
20191×
0.22Jun 12, 2019
20181×
0.21Jun 20, 2018

Stock Splits

  • May 31, 20231.4:1
  • May 27, 20221.3:1
  • Jun 12, 20191.5:1
  • Jun 20, 20181.2:1